7Baggers
 Rhythm Pharmaceuticals (RYTM) Showcases Promising Obesity Drug D  GuruFocus Mon, 10 Nov 2025 14:36:48 GMT
 FDA extends review period for Rhythm’s Imcivree  The Pharma Letter Mon, 10 Nov 2025 14:17:28 GMT
 rhythm announces presentation of four datasets at obesityweek  TipRanks Mon, 10 Nov 2025 13:26:21 GMT
 health care stocks and biotech funds take a hit  Finimize Sat, 08 Nov 2025 00:39:59 GMT
 Rhythm Pharmaceuticals stock dips as Goldman Sachs lowers price target  Investing.com Fri, 07 Nov 2025 20:44:18 GMT
 rhythm's imcivree faces extended fda clock in hypothalamic obesity bid  FirstWord Pharma Fri, 07 Nov 2025 15:18:35 GMT
 rhythm pharmaceuticals stock falls after fda extends review period  Investing.com Fri, 07 Nov 2025 14:30:41 GMT
 Rhythm Pharmaceuticals Faces FDA Review Extension  MSN Fri, 07 Nov 2025 14:03:45 GMT
 rhythm announces fda extension of review period for imcivree  TipRanks Fri, 07 Nov 2025 13:15:28 GMT
 rhythm pharma down as fda delays imcivree label expansion  Seeking Alpha Fri, 07 Nov 2025 13:08:26 GMT
 rhythm forced to wait for imcivree expansion as fda delays decision  Pharmaceutical Technology Fri, 07 Nov 2025 08:00:00 GMT
 why rhythm pharmaceuticals shares are shifting  TipRanks Thu, 06 Nov 2025 09:35:48 GMT
 oppenheimer downgrades rhythm pharmaceuticals (rytm) to a hold  The Globe and Mail Thu, 06 Nov 2025 08:00:00 GMT
 published on: 2025-11-06 01:43:02  newser.com Thu, 06 Nov 2025 07:43:02 GMT
 rytm - rhythm pharmaceu latest stock news & market updates  Stock Titan Wed, 05 Nov 2025 21:01:00 GMT
 rhythm pharmaceuticals shares fall after oppenheimer downgrade  MarketScreener Wed, 05 Nov 2025 19:36:11 GMT
 oppenheimer downgrades rhythm pharmaceuticals(rytm.us) to hold rating  富途牛牛 Wed, 05 Nov 2025 12:10:37 GMT
 rhythm pharmaceuticals reports q3 2025 financial results  TipRanks Wed, 05 Nov 2025 05:01:40 GMT
 needham raises price target for rytm to $122, maintains buy rati  GuruFocus Tue, 04 Nov 2025 17:37:14 GMT
 rhythm pharmaceuticals reports q3 eps (82c), consensus (73c)  TipRanks Tue, 04 Nov 2025 16:29:15 GMT
 rhythm pharmaceuticals q3 loss widens, revenue rises  MarketScreener Tue, 04 Nov 2025 13:04:00 GMT
 rhythm pharmaceuticals (rytm) exceeds q3 revenue expectations  GuruFocus Tue, 04 Nov 2025 12:57:20 GMT
 rhythm pharma q3 product revenue up 54% yr/yr on imcivree sales  MarketScreener Tue, 04 Nov 2025 12:16:02 GMT

Rhythm Pharmaceuticals, Inc
(NASDAQ:RYTM) 

RYTM stock logo

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of ...

Founded: 2008
Full Time Employees: 70
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends